abilify asimtufii
(Aripiprazole)Otsuka America Pharmaceutical, Inc
Usage: ABILIFY ASIMTUFII is indicated for the treatment of schizophrenia in adults and for maintenance monotherapy of bipolar I disorder in adults.
Neurology & Sleep drugs
62 results
aimovig
(erenumab-aooe)Amgen IncUsage: AIMOVIG is indicated for the preventive treatment of migraines in adults.ambien
(zolpidem tartrate)sanofi-aventis U.S. LLCUsage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep initiation. It effectively reduces sleep latency for up to 35 days, as demonstrated in controlled clinical studies lasting 4–5 weeks.ambien
(zolpidem tartrate)sanofi-aventis U.S. LLCUsage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, particularly for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset. Clinical trials supporting its efficacy lasted up to 24 weeks.amvuttra
(VUTRISIRAN)Alnylam Pharmaceuticals, Inc.Usage: AMVUTTRA is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.apokyn
(APOMORPHINE HYDROCHLORIDE)MDD US Operations, LLCUsage: APOKYN (apomorphine hydrochloride injection) is indicated for the acute, intermittent treatment of hypomobility during "off" episodes in advanced Parkinson's disease, including "end-of-dose wearing off" and unpredictable "on/off" episodes. It is studied as an adjunct to other medications.aptiom
(ESLICARBAZEPINE ACETATE)Sumitomo Pharma America, Inc.Usage: APTIOM is used to treat partial-onset seizures in patients aged 4 years and older.austedo
(Deutetrabenazine)Teva Neuroscience, Inc.Usage: AUSTEDO XR and AUSTEDO are indicated for the treatment of chorea associated with Huntington's disease and tardive dyskinesia in adults.belsomra
(suvorexant)Merck Sharp & Dohme LLCUsage: BELSOMRA® (suvorexant) is indicated for treating insomnia, specifically for individuals who have trouble with sleep onset and/or sleep maintenance.brineura
(cerliponase alfa)BioMarin Pharmaceutical Inc.Usage: BRINEURA is indicated to slow the loss of ambulation in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), associated with tripeptidyl peptidase 1 (TPP1) deficiency.